TREX2 Exonuclease Causes Spontaneous Mutations and Stress-Induced Replication Fork Defects in Cells Expressing RAD51

DNA damage tolerance double-strand break repair genomic instability homologous recombination replication fork maintenance

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
22 12 2020
Historique:
received: 16 10 2019
revised: 23 04 2020
accepted: 01 12 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 22 12 2021
Statut: ppublish

Résumé

DNA damage tolerance (DDT) and homologous recombination (HR) stabilize replication forks (RFs). RAD18/UBC13/three prime repair exonuclease 2 (TREX2)-mediated proliferating cell nuclear antigen (PCNA) ubiquitination is central to DDT, an error-prone lesion bypass pathway. RAD51 is the recombinase for HR. The RAD51 K133A mutation increased spontaneous mutations and stress-induced RF stalls and nascent strand degradation. Here, we report in RAD51

Identifiants

pubmed: 33357432
pii: S2211-1247(20)31532-1
doi: 10.1016/j.celrep.2020.108543
pmc: PMC7896812
mid: NIHMS1657609
pii:
doi:

Substances chimiques

Phosphoproteins 0
RAD51 protein, human EC 2.7.7.-
Rad51 Recombinase EC 2.7.7.-
Exodeoxyribonucleases EC 3.1.-
TREX2 protein, human EC 3.1.16.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

108543

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES022054
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188032
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG017242
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : Wellcome Trust
ID : 206292/E/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

DNA Repair (Amst). 2012 Oct 1;11(10):789-98
pubmed: 22921573
J Cell Biol. 2019 Apr 1;218(4):1096-1107
pubmed: 30670471
Nat Genet. 2010 May;42(5):406-9
pubmed: 20400963
Nat Rev Genet. 2007 Oct;8(10):735-48
pubmed: 17768402
Cell Res. 2008 Jan;18(1):148-61
pubmed: 18166979
Genesis. 2007 May;45(5):275-81
pubmed: 17457929
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5287-92
pubmed: 9560268
Nucleic Acids Res. 2007;35(8):2682-94
pubmed: 17426129
Nat Commun. 2017 Oct 16;8(1):859
pubmed: 29038466
J Biol Chem. 2001 May 18;276(20):17022-9
pubmed: 11279105
Curr Pharm Des. 2019;25(30):3239-3247
pubmed: 31475890
Genesis. 2011 Feb;49(2):92-7
pubmed: 21344611
Nat Struct Mol Biol. 2013 Mar;20(3):347-54
pubmed: 23396353
Mol Cell. 2014 Jun 5;54(5):858-69
pubmed: 24905007
Med Oncol. 2011 Jun;28(2):434-40
pubmed: 20354821
Methods Enzymol. 2014;546:319-36
pubmed: 25398347
Blood. 2002 Oct 1;100(7):2414-20
pubmed: 12239151
Nature. 1997 Apr 24;386(6627):804-10
pubmed: 9126738
Nucleic Acids Res. 2019 Aug 22;47(14):7163-7181
pubmed: 31251805
Sci Rep. 2016 Oct 12;6:35218
pubmed: 27731420
Nucleic Acids Res. 1997 Feb 15;25(4):868-72
pubmed: 9016639
Cell. 2007 Dec 28;131(7):1228-30
pubmed: 18160033
Transl Cancer Res. 2013;2(3):107-129
pubmed: 24058901
J Cell Biol. 2004 Aug 16;166(4):493-505
pubmed: 15302854
Nat Genet. 2004 Nov;36(11):1219-24
pubmed: 15502827
Nature. 2013 Sep 26;501(7468):569-72
pubmed: 24013173
Mutat Res. 2011 Jul 1;712(1-2):20-7
pubmed: 21458466
Nucleic Acids Res. 2018 May 4;46(8):3967-3980
pubmed: 29481689
Science. 2002 Jul 26;297(5581):599-602
pubmed: 12142537
Mol Cells. 2008 Jul 31;26(1):5-11
pubmed: 18525240
Mol Cell Biol. 2012 Sep;32(18):3663-80
pubmed: 22778135
EBioMedicine. 2016 Apr;6:73-86
pubmed: 27211550
Exp Cell Res. 1989 Apr;181(2):305-16
pubmed: 2647496
Mol Cell. 2017 Sep 7;67(5):882-890.e5
pubmed: 28886337
DNA Repair (Amst). 2011 Apr 3;10(4):438-44
pubmed: 21269891
J Biol Chem. 2005 Apr 15;280(15):15212-8
pubmed: 15661738
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W401-7
pubmed: 24861617
Cancer Cell. 2012 Jul 10;22(1):106-16
pubmed: 22789542
Hum Mol Genet. 2020 Oct 20;29(R2):R158-R164
pubmed: 32420592
Curr Opin Cell Biol. 2016 Jun;40:137-144
pubmed: 27060551
Genesis. 2008 Dec;46(12):732-7
pubmed: 18932256
J Biol Chem. 2006 Apr 28;281(17):11649-57
pubmed: 16513631
Genes Dev. 2001 Dec 15;15(24):3308-18
pubmed: 11751636
Cell Rep. 2014 Jun 26;7(6):1849-57
pubmed: 24910428
Genes Dev. 2011 Jun 15;25(12):1320-7
pubmed: 21685366
AIMS Genet. 2019 Apr 3;5(4):192-211
pubmed: 31435521
Genetics. 2011 Aug;188(4):787-97
pubmed: 21546543
Nucleic Acids Res. 2015 Mar 11;43(5):2678-90
pubmed: 25672394
Nat Protoc. 2012 Mar 01;7(3):594-605
pubmed: 22383038
Mol Cell Biol. 2010 Sep;30(17):4120-33
pubmed: 20606006
Mol Cell Biol. 1991 Sep;11(9):4509-17
pubmed: 1875936
Genes Dev. 1991 Sep;5(9):1513-23
pubmed: 1653172
Nucleic Acids Res. 2012 Jul;40(13):5795-818
pubmed: 22467216
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12411-6
pubmed: 18719106
DNA Repair (Amst). 2006 Mar 7;5(3):381-91
pubmed: 16388992
J Biol Chem. 1999 Jul 9;274(28):19655-60
pubmed: 10391904
Cell. 2011 May 13;145(4):529-42
pubmed: 21565612
Annu Rev Biochem. 2005;74:317-53
pubmed: 15952890
J Cell Biol. 2015 Mar 2;208(5):563-79
pubmed: 25733714
Nat Struct Mol Biol. 2018 Jun;25(6):446-453
pubmed: 29807999
J Mol Biol. 2013 Nov 29;425(23):4733-44
pubmed: 23643490
PLoS Genet. 2011 Sep;7(9):e1002262
pubmed: 21931560
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mutat Res. 2009 Mar 9;662(1-2):84-7
pubmed: 19094998
Mol Cell. 2010 Feb 26;37(4):492-502
pubmed: 20188668
DNA Repair (Amst). 2015 May;29:56-64
pubmed: 25655219
Nat Commun. 2016 Feb 15;7:10660
pubmed: 26876348
PLoS One. 2015 Feb 18;10(2):e0118775
pubmed: 25692884

Auteurs

Jun Ho Ko (JH)

Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health San Antonio, San Antonio, TX 78245, USA.

Mi Young Son (MY)

Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health San Antonio, San Antonio, TX 78245, USA; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio, San Antonio, TX 78245, USA.

Qing Zhou (Q)

Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health San Antonio, San Antonio, TX 78245, USA.

Lucia Molnarova (L)

Department of Biology, Masaryk University, Kamenice 5/A7, 625 00 Brno, Czech Republic.

Lambert Song (L)

Department of Genetics, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA.

Jarmila Mlcouskova (J)

International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Pekarska 53, 656 91 Brno, Czech Republic.

Atis Jekabsons (A)

National Centre for Biomolecular Research, Masaryk University, Kamenice 5/A7, 625 00 Brno, Czech Republic; International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Pekarska 53, 656 91 Brno, Czech Republic.

Cristina Montagna (C)

Department of Genetics, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA.

Lumir Krejci (L)

National Centre for Biomolecular Research, Masaryk University, Kamenice 5/A7, 625 00 Brno, Czech Republic; Department of Biology, Masaryk University, Kamenice 5/A7, 625 00 Brno, Czech Republic; International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Pekarska 53, 656 91 Brno, Czech Republic.

Paul Hasty (P)

Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health San Antonio, San Antonio, TX 78245, USA; The Cancer Therapy & Research Center, University of Texas Health San Antonio, San Antonio, TX 78229, USA; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio, San Antonio, TX 78245, USA. Electronic address: hastye@uthscsa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH